Ethosuximide
- Strength
- 250 mg/5mL
- Form
- Solution
- Class
- Anti-epileptic Agent
Chartwell RX, LLC
Not stocked by us — reference only
Ethosuximide
Listed by Parke-Davis Div of Pfizer Inc
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Anti-epileptic Agent |
| Approval route | NDA — original brand approval |
| NDC code | 0071-0237 |
| FDA application | NDA012380 |
| RxNorm concept | 197682 |
| Package sizes listed | 1 |
| Marketed since | September 2000 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Chartwell RX, LLC
Not stocked by us — reference only
PAI Holdings, LLC dba PAI Pharma
Not stocked by us — reference only
Bryant Ranch Prepack
Not stocked by us — reference only
Strides Pharma Science Limited
Not stocked by us — reference only
Mylan Pharmaceuticals Inc.
Not stocked by us — reference only
Chartwell RX, LLC
Not stocked by us — reference only
Bionpharma Inc.
Not stocked by us — reference only
Epic Pharma, LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.